Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1985 Sep;5(5):287-97.
doi: 10.1007/BF00918247.

An update on human interleukin-1: from molecular biology to clinical relevance

Review

An update on human interleukin-1: from molecular biology to clinical relevance

C A Dinarello. J Clin Immunol. 1985 Sep.

Abstract

Interleukin-1 (IL-1) represents a family of polypeptides with a wide range of biological activities. At least two dissimilar gene products have been cloned; there are probably more. The human IL-1 family plays an important role in the pathogenesis of many diseases and functions as a key mediator of the host response to various infectious, inflammatory, and immunologic challenges. Recombinant mouse (pI 5) and recombinant human (pI 7) IL-1's are being used to confirm the multiple biological properties of IL-1's but considerable investigation is required before the specific activities (biological units per milligram of protein) are established for each human IL-1 form. Some IL-1 biological activities such as the induction of hepatic acute-phase protein synthesis have been demonstrated in invertebrates predating the evolution of lymphocytes. IL-1 is highly inflammatory and increases the concentration of metabolites of arachidonic acid, most notably prostaglandin E2, in brain, muscle, chondrocytes, and synovial fibroblasts. The synthesis of leukotrienes also is involved in the mechanism of its action on certain tissues. The cloning and expression of human IL-1 genes will expand our understanding of IL-1 in various diseases through improved detection systems and the use of cDNA probes; the development of IL-1 antagonists, as well as the use of IL-1 as an immunomodulator, is presently being considered.

PubMed Disclaimer

References

    1. J Exp Med. 1972 Jul 1;136(1):143-55 - PubMed
    1. J Immunol. 1985 Jan;134(1):157-66 - PubMed
    1. J Exp Med. 1984 Aug 1;160(2):618-23 - PubMed
    1. Nature. 1985 Mar 21-27;314(6008):266-8 - PubMed
    1. Arteriosclerosis. 1985 Mar-Apr;5(2):186-91 - PubMed

Publication types

LinkOut - more resources